Klarmin

Clarithromycin, the active ingredient in Klarmin, is a macrolide antibiotic presented as a tablet for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, chronic bronchitis exacerbations, and skin and soft‑tissue infections in adults and children as prescribed.

GNH USA supplies Klarmin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin acts on bacterial protein synthesis, making it effective for several respiratory and skin infections. - Community‑acquired pneumonia: eradicates causative bacteria and improves clinical recovery. - Acute bacterial sinusitis: reduces bacterial load and alleviates sinus inflammation. - Acute exacerbations of chronic bronchitis: shortens illness duration and prevents complications. - Skin and soft‑tissue infections: treats staphylococcal and streptococcal skin infections.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools that may be watery. - Abdominal pain: cramping or discomfort in the abdomen. - Taste disturbance: altered sense of taste, often metallic. - Headache: mild to moderate head pain. - Vomiting: occasional expulsion of stomach contents.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - Hepatotoxicity: elevated liver enzymes or jaundice. - QT prolongation: heart rhythm changes that may lead to arrhythmia. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Severe cardiac arrhythmias: irregular heartbeats that can be life‑threatening.

Clarithromycin should be used with caution in specific patient groups and clinical situations. - Pregnancy: Category B; prescribe only when benefit outweighs potential risk. - Renal impairment: dose adjustment may be necessary; monitor kidney function. - Hepatic impairment: monitor liver enzymes; consider dose reduction. - Drug interactions: avoid concomitant use with strong CYP3A4 inhibitors. - QT prolongation risk: monitor ECG in patients with cardiac history. - Store at ambient temperature (below 25°C): keep in original packaging, protect from moisture.

Clarithromycin can interact with several medicines, requiring attention to avoid adverse outcomes. Major Interactions (Avoid): - Erythromycin: additive risk of QT prolongation. - Cisapride: may cause serious cardiac arrhythmias. - Astemizole: increased risk of QT prolongation. - Terfenadine: heightened potential for cardiac events. Moderate Interactions (Monitor Closely): - Simvastatin: elevated plasma levels may increase myopathy risk. - Warfarin: enhanced anticoagulant effect; monitor INR closely.